Ad Code: 79865

Study results indicate that patients with IgA nephropathy reported a 50% reduction in proteinuria at 36 weeks, compared with a 15% reduction in those treated with irbesartan. The rate of complete remission was significantly...

For patients with locally advanced or metastatic renal cell carcinoma with disease progression on or after immune checkpoint inhibitor treatment, the addition of atezolizumab to cabozantinib does not improve clinical outcomes,...